Amicus Therapeutics Inc. – Filings and Transcripts

NASDAQ: FOLD
Share price (4/7/26): $14.47
Market cap (4/7/26): $4.544 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Automatic shelf registration

Ownership Filter

Vanguard Group Inc

Campbell Bradley L

Campbell Bradley L

Wellington Management Group Llp

William Blair Investment Management, LLC

News Filter

Shareholder Vote Results, Financial Statements or Exhibits

Announces Full-Year 2025 Financial Results and Corporate Updates

Earnings Release or Operating Update, Material Disclosure

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

Announces Third Quarter 2025 Financial Results and Corporate Updates

Proxies Filter

Additional info about upcoming vote

Proxy related to merger

Additional info about upcoming vote

Preliminary proxy related to merger

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Confidential treatment order